Article ID Journal Published Year Pages File Type
8759292 Journal of the Formosan Medical Association 2018 10 Pages PDF
Abstract
Peg-IFN/ribavirin was effective and tolerable for thalassemic HCV patients. Successful antiviral therapy might have extra benefit of reducing the post-treatment transfusion demand.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
Authors
, , , , , , , , , , , , , , ,